• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Medgadget Visits Healthcareᐩ Expo Taiwan

      Medgadget Visits Healthcareᐩ Expo Taiwan

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

    • Radiology
      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Fluorescence Imaging System Illuminates Tumor Depth

      Fluorescence Imaging System Illuminates Tumor Depth

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

      Mining Ultrasound Data to Improve Liver Diagnostics: Interview with Beth Rogozinski, CEO at Oncoustics

      Mining Ultrasound Data to Improve Liver Diagnostics: Interview with Beth Rogozinski, CEO at Oncoustics

    • Cardiology
      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Surgery
      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Electrospun Construct Mimics Elasticity of Blood Vessels

      Electrospun Construct Mimics Elasticity of Blood Vessels

    • Nanomedicine
      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Magnetic Bacteria Target Tumors

      Magnetic Bacteria Target Tumors

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Implanted Magnets for Prosthetic Control

      Implanted Magnets for Prosthetic Control

      FDA-Approved At-Home Spirometer: Interview with Charvi Shetty, Co-Founder and CEO at Aluna

      FDA-Approved At-Home Spirometer: Interview with Charvi Shetty, Co-Founder and CEO at Aluna

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

GLP-1 Receptor Agonist Market Will Generate Massive Growth 2022-2028 | Eli Lilly and Company, GlaxoSmithKline plc, Novo Nordisk A/S

February 10th, 2022 Coherent Market Insights Releases

Glucagon-like peptide-1 agonists are used in the treatment of type 2 diabetes and obesity. Long-acting GLP-1 RAs approved for use in the U.S include: dulaglutide (Trulicity), exenatide extended-release (Bydureon), liraglutide (Victoza), and semaglutide (Ozempic).

The global GLP-1 receptor agonist market is estimated to be valued at US$ 12,720.6 million in 2021 and is expected to exhibit a CAGR of 6.1% over the forecast period (2022-2028).

Click To get Free SAMPLE PDF (Including Full TOC, List of Tables & Figures, Chart) @
https://www.coherentmarketinsights.com/insight/request-sample/4632

Market Drivers:

Approval and launch of new products is expected to propel growth of the global GLP-1 receptor agonist market over the forecast period. For instance, the U.S. Food and Drug Administration approved two additional doses of Eli Lilly and Company’s GLP-1 receptor agonist drug, Trulicity (dulaglutide) used for the treatment of type-2 diabetes, in September 2020.

Moreover, high prevalence of diabetes is also expected to propel growth of the global GLP-1 receptor agonist market over the forecast period. For instance, according to the study, ‘Global Prevalence of Type 2 Diabetes over the Next Ten Years (2018-2028)’, published by the American Diabetes Association, 500 million people worldwide suffered from type 2 diabetes in 2018.

Market Opportunities:

R&D of new products is expected to offer lucrative growth opportunities for players in the global GLP-1 receptor agonist market. For instance, 9 Meters Biopharma, Inc., in July 2020, started a clinical trial to assess the efficacy and safety of its drug candidate NM-002, a glucagon-like peptide-1 (GLP-1) receptor agonist for the treatment of short bowel syndrome.

Covid-19 Impact Analysis:

Higher BMI increases the risk of COVID-19 infection. According to a study published by the World Obesity Federation, around 10.5% of positive COVID-19 test results in the U.S were due to obesity during March 1, 2020 and May 14, 2020. Such scenario is expected to boost demand for GLP-1 receptor agonist.

Ask for PDF Brochure @
https://www.coherentmarketinsights.com/insight/request-pdf/4632

Regional Analysis:

Asia Pacific is expected to witness significant growth in the global GLP-1 receptor agonist market, owing to high prevalence of obesity in the region. For instance, the combined prevalence of obesity in Australia is expected to increase from 26% in 2019 to 35% by 2025, according to a study published in Nature in May 2021.

Market Trends:

Major players operating in the global GLP-1 receptor agonist market are focused on approval and launch of new products to expand their product portfolio. For example, the European Medicines Agency, in April 2020, approved Rybelsus (semaglutide) from Novo Nordisk A/S for the treatment of Type-2 diabetes.

Market Restraints:

Side effects of certain drugs have led to decline in their sale, which is expected to limit growth of the global GLP-1 receptor agonist market over the forecast period. For example, GlaxoSmithKline plc, in July 2017, withdrew Tanzeum (albiglutide) from the market as sales of the GLP-1 receptor agonist drug declined majorly due to risk of renal impairment, pancreatitis, and diabetic ketoacidosis in diabetic patients.

Key Players

Major players operating in the global GLP-1 receptor agonist market include, Amylin Pharmaceuticals, Inc., Amgen Inc., AstraZeneca, Eli Lilly and Company, GlaxoSmithKline plc, Hanmi Pharm. Co., Ltd., Intarcia Therapeutics, Inc., Innovent Biologics, Jiangsu Hengrui Medicine Co., Novo Nordisk A/S, PegBio Co., Ltd., Pfizer Inc., Sanofi, Sun Pharmaceuticals Industries Ltd., and 9 Meters Biopharma, Inc.

Reasons to Buy this GLP-1 Receptor Agonist Market Report

➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging GLP-1 Receptor Agonist market

➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging GLP-1 Receptor Agonist market

➡Leading company profiles reveal details of key GLP-1 Receptor Agonist market players emerging five operations and financial performance

➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging GLP-1 Receptor Agonist market with five year historical forecasts

➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .

𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
https://www.coherentmarketinsights.com/promo/buynow/4632

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 GLP-1 Receptor Agonist Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: GLP-1 Receptor Agonist Industry Impact

Chapter 2 Global GLP-1 Receptor Agonist Competition by Types, Applications, and Top Regions and Countries
2.1 Global GLP-1 Receptor Agonist (Volume and Value) by Type
2.3 Global GLP-1 Receptor Agonist (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global GLP-1 Receptor Agonist Sales, Consumption, Export, Import by Regions
Chapter 5 North America GLP-1 Receptor Agonist Market Analysis
Chapter 6 East Asia GLP-1 Receptor Agonist Market Analysis
Chapter 7 Europe GLP-1 Receptor Agonist Market Analysis
Chapter 8 South Asia GLP-1 Receptor Agonist Market Analysis
Chapter 9 Southeast Asia GLP-1 Receptor Agonist Market Analysis
Chapter 10 Middle East GLP-1 Receptor Agonist Market Analysis
Chapter 11 Africa GLP-1 Receptor Agonist Market Analysis
Chapter 12 Oceania GLP-1 Receptor Agonist Market Analysis
Chapter 13 South America GLP-1 Receptor Agonist Market Analysis
Chapter 14 Company Profiles and Key Figures in GLP-1 Receptor Agonist Business
Chapter 15 Global GLP-1 Receptor Agonist Market Forecast (2021-2028)
Chapter 16 Conclusions
Research Methodology….

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Sign up and submit a press release

Sponsored
New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Unveils New Embolic for Neurovascular Use

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

PT Genie Unveils New Brand Identity Reflecting Company’s Transformation and Focus on the Global Future of AI and Machine Learning in Digital Healthcare

Clarius Marketplace Unlocks the Power of AI Innovation for Ultrasound Imaging

Clarius Marketplace Unlocks the Power of AI Innovation for Ultrasound Imaging

interviews & reviews
Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email